KUWAIT MEDICAL JOURNAL, cilt.43, sa.3, ss.227-229, 2011 (SCI-Expanded)
Although there have been a few reports regarding fenofibrate-induced rhabdomyolysis in patients with hypothyroidism, there are no data in literature that this could occur in patients with subclinical hypothyroidism. We report a case of subclinical hypothyroidism and end-stage renal failure who presented with rhabdomyolysis while taking fenofibrate for dyslipidemia.